Form 4: Darling Ingredients Director Acquires 1,328 Shares

Sentiment:

Insider Transaction Report


Darling Ingredients Director Celeste A. Clark acquired 1,328 shares of common stock through deferred stock units, vesting fully by December 31, 2026.

Summary

  • Director Celeste A. Clark acquired 1,328 shares of Darling Ingredients Inc. common stock.
  • The acquisition occurred on January 2, 2026, at a price of $37.64 per share.
  • These shares are in the form of Deferred Stock Units (DSUs) granted under the 2017 Omnibus Incentive Plan.
  • The number of DSUs was determined by the portion of annual cash compensation elected by the director, divided by the closing market price on the transaction date.
  • Following this transaction, Celeste A. Clark beneficially owns 17,521 shares of common stock directly.
  • The DSUs are scheduled to vest in full on December 31, 2026.
  • A prorated portion of DSUs will vest if the director ceases service before December 31, 2026, with unvested units being forfeited.

Sentiment

Score: 7

Explanation: The filing reports a routine director compensation grant, which is a positive for aligning interests but does not indicate significant new operational or financial news. The increase in director ownership is generally viewed favorably.

Positives

  • Director Celeste A. Clark increased her beneficial ownership in Darling Ingredients Inc. by acquiring 1,328 shares.
  • The acquisition was part of a compensation plan (Deferred Stock Units), aligning director interests with shareholder value.

Risks

  • The Deferred Stock Units (DSUs) are subject to vesting conditions; if the reporting person ceases to serve as a director prior to December 31, 2026, only a prorated portion will vest, and unvested DSUs will be forfeited.

Future Outlook

The Deferred Stock Units are set to vest fully on December 31, 2026, indicating a future commitment and potential increase in the director's vested equity holdings.

Management Comments

  • Deferred Stock Units (DSU's) granted in accordance with the 2017 Omnibus Incentive Plan.
  • The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the annual cash compensation the reporting person elected to receive in DSU's, divided by the closing market price of a share of the issuer's common stock on January 2, 2026.
  • These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSU's will vest in a prorated portion based on the reporting person's time of service and the unvested DSU's will be forfeited.

Industry Context

This transaction is a routine insider filing (Form 4) reporting a director's equity compensation. It reflects standard corporate governance practices where directors receive a portion of their compensation in company stock or stock equivalents to align their interests with long-term shareholder value. It does not provide broader industry trends.

Comparison to Industry Standards

  • The use of Deferred Stock Units (DSUs) as part of director compensation is a common practice across many publicly traded companies, particularly in industries like specialty ingredients and renewable fuels, to foster long-term alignment.
  • The vesting schedule, with full vesting by year-end, is typical for annual equity grants to non-employee directors, similar to practices seen at peers like Tyson Foods (TSN) or Archer-Daniels-Midland (ADM) which also utilize equity-based compensation plans for their boards.
  • The forfeiture clause for unvested DSUs upon cessation of service is a standard mechanism to ensure continued commitment and service from board members.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Compensation GrantGrant of Deferred Stock Units (DSUs) to a director under the 2017 Omnibus Incentive Plan, aligning director compensation with company performance and shareholder interests.2026-01-02Enhances alignment of director's financial interests with long-term shareholder value and retention of board members.

Related Party Transactions

  • The grant of Deferred Stock Units (DSUs) to Director Celeste A. Clark is a related party transaction as it involves compensation from the company to a board member. This is a standard practice under the company's 2017 Omnibus Incentive Plan.

Stakeholder Impact

  • Shareholders: Increased alignment of director's interests with shareholder value through equity compensation.

Next Steps

  • The acquired Deferred Stock Units (DSUs) are scheduled to vest in full on December 31, 2026.

Key Dates

DateDescription
2025-11-05Celeste A. Clark executed a Power of Attorney appointing attorneys-in-fact for SEC filings.
2026-01-02Date of earliest transaction: Acquisition of 1,328 Deferred Stock Units (DSUs) at $37.64 per share.
2026-01-06Date Form 4 was signed by attorney-in-fact.
2026-12-31Full vesting date for the acquired Deferred Stock Units (DSUs).
2028-03-18Expiration date of the notary public's commission for the Power of Attorney.

Recommendation

hold

This Form 4 filing details a routine grant of Deferred Stock Units to a director as part of their compensation. While it shows continued insider ownership and alignment of interests, it does not present new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure of an expected event.

Keywords

Darling Ingredients, DAR, Celeste A. Clark, Director, Stock Acquisition, Deferred Stock Units, DSU, Insider Trading, SEC Form 4, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.